Case Study: Fortune 100 Biopharmaceutical Company achieves a profitable, consumer-centered go-to-market framework for disease prevention with Advarra

Multi-Disciplinary Teams Deliver a Framework for a Profitable Go-to-Market Strategy

Fortune 100 Biopharmaceutical Company was pursuing an innovation initiative to identify and develop disease-prevention product concepts that represented a significant departure from its traditional therapies and might require novel regulatory pathways. To ensure a successful and profitable go-to-market strategy it needed diverse perspectives and expert strategic roadmaps, so it engaged Advarra and its innFusion™ methodology to provide the multidisciplinary expertise required.

Advarra mobilized bespoke, multidisciplinary teams to bring regulatory, payer, OTC, digital/mobile health and other perspectives, using innFusion™ to evaluate assets, ideate solutions, and define clear next steps. The engagement delivered a holistic, consumer-centered framework that enables the client to pivot to a new, profitable business model, increased the probability of success per client feedback, and continues with Advarra as an ongoing partner through execution.